单肺通气预处理对胸腔镜手术患者围术期脑保护的作用

注册号:

Registration number:

ChiCTR2000040506 

最近更新日期:

Date of Last Refreshed on:

2021-03-07 18:19:41 

注册时间:

Date of Registration:

2020-12-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

单肺通气预处理对胸腔镜手术患者围术期脑保护的作用

Public title:

The effect of one-lung ventilation preconditioning on brain protection in patients undergoing thoracoscopic surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

单肺通气预处理对胸腔镜手术患者围术期脑保护的作用

Scientific title:

The effect of one-lung ventilation preconditioning on brain protection in patients undergoing thoracoscopic surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

郭凤英 

研究负责人:

王月兰 

Applicant:

GuoFengying 

Study leader:

WangYuelan 

申请注册联系人电话:

Applicant telephone:

+86 15853115661

研究负责人电话:

Study leader's
telephone:

+86 15953105780

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

guojunjun216@126.com

研究负责人电子邮件:

Study leader's E-mail:

guojunjun216@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省济南市经十路16766号

研究负责人通讯地址:

山东省济南市经十路16766号

Applicant address:

16766 Jingshi Road, Ji'nan, Shandong, China

Study leader's address:

16766 Jingshi Road, Ji'nan, Shandong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东第一医科大学第一附属医院(山东省千佛山医院)

Applicant's institution:

The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)

研究负责人所在单位:

山东第一医科大学第一附属医院(山东省千佛山医院)

Affiliation of the Leader:

The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YXLL-KY-2020(066)

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山东省千佛山医院医学伦理委员会

Name of the ethic committee:

Shandong Qianfoshan Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2020-11-27 00:00:00

伦理委员会联系人:

许冬梅

Contact Name of the ethic committee:

Xu Dongmei

伦理委员会联系地址:

济南市经十路16766号

Contact Address of the ethic committee:

16766 Jingshi Road, Ji'nan, Shandong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山东第一医科大学第一附属医院(山东省千佛山医院)

Primary sponsor:

The First Affiliated Hospital of Shandong First Medical University

研究实施负责(组长)单位地址:

山东省济南市经十路16766号

Primary sponsor's address:

16766 Jingshi Road, Ji'nan, Shandong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东省

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

山东第一医科大学第一附属医院(山东省千佛山医院)

具体地址:

山东省济南市经十路16766号

Institution
hospital:

The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)

Address:

16766 Jingshi Road, Ji'nan

经费或物资来源:

自筹

Source(s) of funding:

self-raised

研究疾病:

围术期管理  

Target disease:

Perioperative management

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

评价在择期胸腔镜手术单肺通气的患者单肺通气预处理对其对脑保护的作用。 研究指标: 1.主要研究指标 ①单肺通气预处理对患者围术期脑氧饱和度及动脉氧分压的影响。 ②单肺通气预处理对患者术后认知功能的影响。 ③单肺通气预处理对患者血清神经元特异性烯醇化酶(neuron- specificenolase,NSE)浓度,及S100β蛋白浓度的影响。 2.次要研究指标 ①单肺通气预处理对患者拔管时间的影响 ②观察单肺通气预处理对单肺通气时肺内分流的影响。  

Objectives of Study:

o evaluate the effect of single-lung ventilation preconditioning on brain protection in patients undergoing one-lung ventilation during elective thoracoscopic surgery. Research indicators: 1. Main research indicators ①The effect of preconditioning for one-lung ventilation on cerebral oxygen saturation and arterial oxygen partial pressure during perioperative period. ②The effect of preconditioning for one-lung ventilation on the postoperative cognitive function of patients. ③The effect of preconditioning for one-lung ventilation on the serum neuron-specific enolase (NSE) concentration and S100β protein concentration. 2. Secondary research indicators ①The influence of one-lung ventilation preconditioning on the patient's extubation time ② To observe the effect of preconditioning for one-lung ventilation on intrapulmonary shunt during one-lung ventilation.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1)拒绝参加本研究;
2)急诊手术;
3)肺功能检查为中重度肺通气和换气功能障碍者;
4)曾行开胸手术病史;
5)严重认知功能损害,如昏迷、痴呆及精神分裂症病史;
6)术中出现严重低氧血症(SPO2<85%),观察3min无改善则排除;
7)ASA III级及以上;
8)严重脑血管疾病者;
9)双侧颈动脉存在狭窄及斑块者。

Exclusion criteria:

1. Refusal to participate in this study;
2. Emergency surgery;
3. Pulmonary function test with moderate to severe lung ventilation and ventilation dysfunction;
4. History of thoracotomy;
5. Severe cognitive impairment, such as coma and dementia And history of schizophrenia;
6. Severe hypoxemia (SPO2<85%) occurred during the operation, and no improvement after observation for 3 minutes will be ruled out;
7. ASA III and above;
8. severe cerebrovascular disease;
9. bilateral Carotid artery stenosis and plaque.

研究实施时间:

Study execute time:

From 2020-12-01 00:00:00 To 2021-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-12-01 00:00:00 To 2021-07-31 00:00:00

干预措施:

Interventions:

组别:

单肺通气预处理组

样本量:

40

Group:

OLV pretreatment group

Sample size:

干预措施:

受侧导管开口连接吸引器以负压(-20Kpa)吸引15sec后封闭,建立单肺预防模型。15min后恢复双肺通气。双腔插管定位成功后,健侧行单肺通气

干预措施代码:

Intervention:

The opening of the receiving side catheter was connected to a suction device and then closed under negative pressure (-20Kpa) for 15 seconds to establish a single lung prevention model. After 15 minutes, both lung ventilation was resumed. After the positioning of the double-lumen cannula is successful, the

Intervention code:

组别:

常规单肺通气组

样本量:

40

Group:

Conventional OLV group

Sample size:

干预措施:

双腔插管定位成功后,双肺通气至开胸后行单肺通气

干预措施代码:

Intervention:

After the double lumen intubation was successfully located, bilateral lung ventilation was performed until thoracotomy

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

山东第一医科大学第一附属医院(山东省千佛山医院) 

单位级别:

三甲医院 

Institution
hospital:

The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

局部脑氧饱和度

指标类型:

主要指标

Outcome:

regional cerebral oxygen saturation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

神经元特异性烯醇化酶

指标类型:

主要指标

Outcome:

neuron- specificenolase

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

S100β蛋白

指标类型:

主要指标

Outcome:

S100 beta protein

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

简易智能精神量表评分

指标类型:

次要指标

Outcome:

mini - mental state examination

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 55 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

成果发表后1年,经认证的,以科学研究为目的的研究者可向项目负责人申请原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

One year after publication, accredited researchers for scientific purposes can apply to the project leader for the original data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-12-01 06:04:04